Skip to content
Manufacturing, Medical Health Aged Care

Iconic Australian Dermatological Skincare Company Celebrates 30 Years of Success in the Middle East

Ego Pharmaceuticals 2 mins read

Ego Pharmaceuticals, a leading Australian dermatological skincare company is proudly celebrating two major milestones this year, with 70 years of operations globally and 30 years in the Middle East.

Ego Pharmaceuticals became the first Australian skincare company to venture into the Middle East, despite being relatively unknown at the time. Over three decades, Ego has solidified its presence in the region, which currently contributes to 50% of its total exports and 25% of its overall global business.

With a workforce of 110 professionals across 7 Middle Eastern countries, Ego Pharmaceuticals is moving to a new MEA support centre in central Dubai this September and expanding operations in Saudi Arabia later in the year.

Alan Oppenheim, Managing Director, said of the company's journey: "Ego's entry into the Middle East was a significant leap for our small company. Looking back on the collective efforts of our teams in Australia and the Middle East over these three decades fills me with immense pride. Knowing that our products have played a role in improving the lives of those in the Middle East dealing with chronic skin conditions is truly gratifying. We are now a leading Australian company with sustainable operations in a vibrant and growing Middle East market."

Ego Pharmaceuticals' dedication to the Middle East has resulted in consistent growth. From its initial entry into the UAE in 1993, the company expanded its presence into Bahrain, Jordan, Saudi Arabia, Kuwait, Qatar, and Oman. Recognitions include awards at the Australian Export Awards for Health and Biotechnology in 2015, as well as the Manufacturing Export Award and Australian Exporter of the Year title in 2017.

Ego's thriving export success to the Middle East has led to significant investments in its Australian operations, based in Melbourne, including current projects to upgrade to its manufacturing facility and the expansion of its global distribution centre. These initiatives are expected to increase production capacity by 100% and create 90 new jobs.

For media inquiries, please contact:

Marketing.MiddleEast@egopharm.com

 

 


About us:

About Ego Pharmaceuticals: Proudly Australian owned and made, Ego Pharmaceuticals has led the way in the development, manufacture and marketing of innovative dermatological products for 70 years. Today the company produces over 120 different products including the QV Skincare range, DermAid, MOOV and SunSense. Ego’s mission is to exist for people who want healthy looking skin by being the specialist in skincare, backed by science. Visit us   www.egopharm.com/middle-east


Contact details:

marketing.middleeast@egopharm.com

Media

More from this category

  • Medical Health Aged Care
  • 18/10/2024
  • 10:22
Royal Australian College of GPs

‘Fantastic milestone’ for 88 new specialist GPs in South Australia

The Royal Australian College of GPs will welcome 88 new fellows as specialist GPs in South Australia at a ceremony on Saturday 19 October, which will also celebrate the state’s annual RACGP Award winners. The new GPs attending the event in Adelaide Town Hall will include eight rural generalists – GPs who’ve completed Additional Rural Skills Training in fields such as anaesthesia and obstetrics. Fellowship of the RACGP (FRACGP) reflects a doctor’s qualification and expertise as a specialist GP and is the culmination of around 11 years of education, training, rigorous assessment, and experience in primary care. RACGP President Dr…

  • Medical Health Aged Care, Science
  • 18/10/2024
  • 09:30
Centenary Institute

Revealing the role of immune cells in liver cancer

New research from the Centenary Institute and the University of Sydney has uncovered important insights into the immune environment within liver cancer, the sixth…

  • Contains:
  • Medical Health Aged Care
  • 18/10/2024
  • 06:35
Royal Australian College of GPs

ACT Labor’s proposed walk-in centres expansion leaves cost and care questions unanswered: RACGP

The Royal Australian College of GPs (RACGP) has reiterated its call for the next ACT government to commit to an independent evaluation of the ACT nurse-led walk-in centres. With ACT Labor announcing an expansion of centres which are reportedly bleeding taxpayers’ money, ahead of this Saturday’s election, the RACGP also gave its assessment of parties’ primary care policies. An independent evaluation of the centres has been a core pillar of the RACGP’s ACT election platform since before a Canberra Times investigation revealed health officials had “buried” $10 million in expenses. Emails obtained under a Canberra Times freedom of information request…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.